Remus Pharmaceuticals Ltd vs Sun Pharmaceutical Industries Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Remus Pharmaceuticals Ltd currently has the stronger revenue growth signal.
Remus Pharmaceuticals Ltd and Sun Pharmaceutical Industries Ltd show active capex signals based on earnings call analysis.
Sun Pharmaceutical Industries Ltd show fundraising activity or capital structure signals.
| Metric | Remus Pharmaceuticals Ltd | Sun Pharmaceutical Industries Ltd |
|---|---|---|
| Current Price | ₹789 | ₹1,964 |
| Market Cap | ₹912.02 Cr. | ₹4.51 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 27.22 | 37.13 |
| ROE (%) | 14 | 16.86 |
| Debt/Equity | 0.05 | 0.07 |
| Sales Growth 5Y (%) | — | 9.87 |
| Profit Growth 5Y (%) | — | 10.8 |
| Promoter Holding (%) | 0.83 | 21 |
| Revenue Rank | Rank 2 | Rank 4 |
| Margin Rank | Rank 1 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | Yes |